Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.7 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |